Fed. Circ. Affirms PTAB Save Of Merck Diabetes Drug Patent

By Adam Lidgett (September 29, 2022, 4:41 PM EDT) -- The Federal Circuit has backed the Patent Trial and Appeal Board's decision to uphold a patent on Merck's blockbuster diabetes drug Januvia, the latest decision in a broader fight between Merck and patent challenger Mylan Pharmaceuticals....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!